REQUEST A DEMO
Total
USD $0.00
Search more companies

Ciruderma Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Ciruderma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ciruderma Sas is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on March 27, 2007. The total number of employees is currently 47 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 11.91% in 2023. Its’ total assets recorded a growth of 45.73%. The enterprise’s net profit margin increased by 0.73% in 2023.

Headquarters
Calle 106 # 53 - 39 Edificio Cosmopolitan Oficina 201
Bogota D.C.; Bogota D.C; Postal Code: 0822

Contact Details: Purchase the Ciruderma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Ciruderma Sas report to view the information.
Outstanding Shares:
Purchase the Ciruderma Sas report to view the information.
Incorporation Date:
March 27, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Ciruderma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.91%
Total operating revenue
13.19%
Operating profit (EBIT)
32.18%
EBITDA
43.03%
Net Profit (Loss) for the Period
40.6%
Total assets
45.73%
Total equity
16.46%
Operating Profit Margin (ROS)
1.2%
Net Profit Margin
0.73%
Return on Equity (ROE)
4.76%
Debt to Equity Ratio
0.26%
Quick Ratio
-0.09%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?